Chiltern announces it was selected as the partner CRO for Karolinska Development
Chiltern announces it was selected as the partner CRO for Karolinska Development, a publicly-traded life sciences investment company that brings selects and develops the most commercially attractive medical innovations to the point of sales or out-licensing to other companies. The extensive CRO selection process began in 2012 and the company states it was selected based on its compatibility with Karolinska's needs for global infrastructure, and approach to deliver on innovation, quality and flexibility.
Read the full release here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.